• Though BE surveillance is recommended by medical societies, there are many challenges to overcome. There is a lack of an accurate and cost-effective screening tool and lack of a well-characterized screening population. There is also little evidence to demonstrate that screening will lead to improved outcomes.
• The study author acknowledges that standard endoscopy is not the ideal screening tool, but advances have been made in the field. There are non-endoscopic techniques such as balloon cytology and imaging techniques such as wireless capsule endoscopy.
• GERD is the strongest risk factor for BE and esophageal cancer, but a defined screening population has yet to be identified. Several studies have identified other risk factors including male sex, Caucasian race, age, obesity, smoking and family history.
More articles on gastroenterology:
CMS: Guidance on colonoscopy anesthesia modifier, X modifiers
Alternative payment models in GI: What’s on the horizon?
3 GI physicians making headlines – April 17, 2015
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
